The Oncology Institute will announce Q2 2026 financial results on August 6, followed by a conference call.
Quiver AI Summary
The Oncology Institute, Inc. (TOI), a leader in community oncology care, announced the release of its second quarter 2026 financial results scheduled for August 6, 2026, followed by a conference call at 5:00 p.m. Eastern Time. Participants can join the call by phone or listen via a webcast on the company's investor relations website. A replay of the call will be available for two weeks following the event. Founded in 2007, TOI provides specialized, value-based cancer care to around 2.1 million patients across over 100 clinics in five states, focusing on innovative treatment options and patient-centric care.
Potential Positives
- The Oncology Institute is scheduled to release its second quarter financial results, which could provide insights into the company's performance and strategic direction, enhancing investor transparency.
- The upcoming conference call allows for direct engagement between the company and its investors, fostering communication and potentially boosting investor confidence.
- The company highlights its growth, operating over 100 clinics and employing more than 400 clinicians, indicating strong operational capabilities and market presence.
- The Oncology Institute's emphasis on delivering specialized, value-based cancer care positions it as a leader in a critical healthcare sector, which may increase attractiveness to investors and partners.
Potential Negatives
- There is a lack of detailed financial guidance or expectations prior to the earnings release, which may create uncertainty among investors about the company's performance.
- The press release does not highlight any recent achievements or positive developments, potentially reflecting challenges or stagnant growth within the company.
- Failure to announce any new partnerships, innovations, or expansions in the press release could suggest limited strategic progress or competitiveness in a rapidly evolving industry.
FAQ
When will The Oncology Institute release its Q2 2026 financial results?
The Oncology Institute will release its second quarter 2026 financial results on August 6, 2026.
What time is the conference call for Q2 financial results?
The conference call will take place at 5:00 p.m. (Eastern Time) on August 6, 2026.
How can I access the conference call?
You can access the call by dialing 1-833-316-1983 for domestic callers and 1-785-838-9310 for international callers.
Is there a replay available for the conference call?
Yes, a replay will be available approximately three hours after the call until August 20, 2026, at 11:59 p.m. (Eastern Time).
Where can I find more information about The Oncology Institute?
For more information, visit The Oncology Institute's website at www.theoncologyinstitute.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TOI Insider Trading Activity
$TOI insiders have traded $TOI stock on the open market 20 times in the past 6 months. Of those trades, 15 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $TOI stock by insiders over the last 6 months:
- JOREY CHERNETT has made 15 purchases buying 777,914 shares for an estimated $2,607,555 and 0 sales.
- MOHIT KAUSHAL has made 0 purchases and 2 sales selling 95,719 shares for an estimated $335,133.
- YALE PODNOS (Chief Medical Officer) has made 0 purchases and 3 sales selling 46,903 shares for an estimated $276,433.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$TOI Revenue
$TOI had revenues of $147.4M in Q1 2026. This is an increase of 41.22% from the same period in the prior year.
You can track TOI financials on Quiver Quantitative's TOI stock page.
You can access data on TOI stock through the Quiver Quantitative API.
$TOI Hedge Fund Activity
We have seen 69 institutional investors add shares of $TOI stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CENTERBOOK PARTNERS LP removed 1,460,889 shares (-48.2%) from their portfolio in Q1 2026, for an estimated $4,484,929
- GOLDMAN SACHS GROUP INC added 781,475 shares (+137.0%) to their portfolio in Q1 2026, for an estimated $2,399,128
- BALYASNY ASSET MANAGEMENT L.P. removed 692,067 shares (-27.5%) from their portfolio in Q1 2026, for an estimated $2,124,645
- ENSIGN PEAK ADVISORS, INC added 626,852 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,924,435
- CITADEL ADVISORS LLC added 608,267 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,867,379
- BLACKROCK, INC. added 510,534 shares (+13.1%) to their portfolio in Q1 2026, for an estimated $1,567,339
- DAUNTLESS INVESTMENT GROUP, LLC added 462,057 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,418,514
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$TOI Price Targets
Multiple analysts have issued price targets for $TOI recently. We have seen 4 analysts offer price targets for $TOI in the last 6 months, with a median target of $8.5.
Here are some recent targets:
- David Larsen from BTIG set a target price of $9.0 on 07/09/2026
- Ben Haynor from Lake Street set a target price of $10.0 on 07/06/2026
- Matthew Shea from Needham set a target price of $7.0 on 06/17/2026
- Yuan Zhi from B. Riley Securities set a target price of $8.0 on 03/13/2026
Full Release
CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its second quarter 2026 financial results on Thursday, August 6, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-833-316-1983 or, for international callers, 1-785-838-9310, and referencing Conference ID: TOI. A replay will be available approximately three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 11162290. The replay will be available until Thursday, August 20, 2026 at 11:59 p.m. (Eastern Time).
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/ .
About The Oncology Institute
Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Media
The Oncology Institute, Inc.
[email protected]
Investors
ICR Healthcare
[email protected]
